Abstract:Key PointsNanotechnology concerns the study of devices that are themselves or have essential components in the 1–1,000 nm dimensional range (that is, from a few atoms to subcellular size).Two main subfields of nanotechnology are nanovectors — for the administration of targeted therapeutic and imaging moieties — and the precise patterning of surfaces.Nanotechnology is no stranger to oncology: liposomes are early examples of cancer nanotherapeutics, and nanoscale-targeted magnetic resonance imaging contrast agents illustrate the application of nanotechnology to diagnostics.Photolithography is a light-directed surface-patterning method, which is the technological foundation of microarrays and the surface-enhanced laser desorption/ionization time-of-flight approach to proteomics. Nanoscale resolution is now possible with photolithography, and will give rise to instruments that can pack a much greater density of information than current biochips.The ability of nanotechnology to yield advances in early detection, diagnostics, prognostics and the selection of therapeutic strategies is predicated based on its ability to 'multiplex' — that is, to detect a broad multiplicity of molecular signals and biomarkers in real time. Prime examples of multiplexing detection nanotechnologies are arrays of nanocantilevers, nanowires and nanotubes.Multifunctionality is the fundamental advantage of nanovectors for the cancer-specific delivery of therapeutic and imaging agents. Primary functionalities include the avoidance of biobarriers and biomarker-based targeting, and the reporting of therapeutic efficacy.Thousands of nanovectors are currently under study. By systematically combining them with preferred therapeutic and biological targeting moieties it might be possible to obtain a very large number of novel, personalized therapeutic agents.Novel mathematical models are needed, in order to secure the full import of nanotechnology into oncology.

Nanotechnologies for noninvasive measurement of drug release.

Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer

Nanotheranostics for Image-Guided Cancer Treatment

Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems

Nanomedicine For Drug Delivery And Imaging: A Promising Avenue For Cancer Therapy And Diagnosis Using Targeted Functional Nanoparticles

The Design and Application of Nanomaterials as Drug Carriers in Cancer Treatment

Real-Time in Vivo Quantitative Monitoring of Drug Release by Dual-Mode Magnetic Resonance and Upconverted Luminescence Imaging

Nanotheranostics: A Cutting-Edge Technology for Cancer Management

Nanooncology: The future of cancer diagnosis and therapy

Recent nanotheranostic approaches in cancer research

Nanotechnology-based drug delivery for cancer

Cancer nanotechnology: opportunities and challenges

Nanotechnology based therapeutic application in cancer diagnosis and therapy

Stimuli Responsive Nanoparticles for Controlled Anti-cancer Drug Release

Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release

Nanoparticles for Cancer Diagnosis, Radionuclide Therapy and Theranostics

New Nanomaterials and Techniques for Tumor-targeted Systems

Nanomaterials in Cancer-Therapy Drug Delivery System

Chemo-drug Controlled-release Strategies of Nanocarrier in the Development of Cancer Therapeutics

Smart Drug-Delivery Systems for Cancer Nanotherapy

Cancer Theranostics with Near-Infrared Light-Activatable Multimodal Nanoparticles.